Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future...

Area of Science:

• Arbovirology
• Epidemiology
• Public Health

Background:

• Oropouche virus (OROV) is an emerging arthropod-borne virus in the Americas.
• Historically forest-restricted, OROV now poses a significant regional and international public health concern.
• The true burden of OROV infection is underestimated due to misdiagnosis and asymptomatic/subclinical cases.

Purpose of the Study:

• To synthesize current evidence on OROV emergence, epidemiology, transmission, and clinical features.
• To identify populations at increased risk and factors influencing disease risk and detection.
• To evaluate progress and challenges in OROV vaccine development.

Main Methods:

• Review of historical emergence and epidemiological data.
• Analysis of seroepidemiological data to assess transmission extent.
• Examination of risk factors including age, pregnancy, immune status, and healthcare accessibility.
• Assessment of preclinical vaccine studies and clinical development barriers.

Main Results:

• OROV transmission is more widespread than routine surveillance indicates.
• Factors like age, pregnancy, immune status, occupational exposure, and healthcare access significantly influence OROV risk and detection.
• Preclinical vaccine candidates show promise, but clinical development faces hurdles.

Conclusions:

• Future OROV vaccine development should prioritize population-specific needs.
• Effective prevention requires integrating vaccination with strengthened surveillance and improved diagnostics.
• Equitable delivery systems are essential for OROV control.